Asymmetrically coated table

A tablet for the controlled release of a drug. The tablet is in the form of an asymmetrically coated tablet so that immediate release or time-delayed release times can be precisely controlled and the extended release slab may provide zero-order or first-order extended release and pulsatile release depending on the excipients used in the tablet formulations.

ABSTRACT

A tablet for the controlled release of a drug. The tablet is in the form of an asymmetrically coated tablet so that immediate release or time-delayed release times can be precisely controlled and the extended release slab may provide zero-order or first-order extended release and pulsatile release depending on the excipients used in the tablet formulations. The core of the tablet is coated with an asymmetrical coating, that is, a coating with regions having different properties. The coatings may include drugs in varying concentrations. Further, different regions of the coating may have different rates of dissolution. The core of the tablet may be provided with a constant cross-sectional area along a longitudinal length of the tablet, a coating having a first region with a more rapid rate of dissolution than a second region. The dissolution of the first region exposes only the cross-sectional area to the dissolution medium. The second region of the coating prevents any other portion of the core of the tablet from being exposed to the dissolution medium. Therefore, since the cross-sectional area remains constant as it is dissolved, the rate of release of the drug from the core of the tablet remains constant. The cross-sectional area may be of any geometrical configuration so long as the area remains constant as the core dissolves.

CLAIMS

1. An asymmetrically coated tablet for extended release of a drug, comprising: a core comprising a drug dispersed throughout said core in at least one excipient; and a coating covering said core, wherein said coating comprises a first region and a second region, wherein said first region of said coating and said second region of said coating do not comprise a drug, wherein said core comprises a cross-sectional area that is constant along an entirety of a longitudinal length of said core such that the rate of release of said drug from said core is constant under conditions effective to dissolve said core, wherein said first region coats a portion of said core such that dissolution of said first region exposes said constant cross-sectional area of said core and said second region coats a remaining portion of said core.

PATENT INFORMATION


Interested in this Technology?

The technologies listed here are available for licensing or for developmental partnership.
Please contact us if you have any questions, or if you would like further information on these or other upcoming BioVentures technologies.

Contact